Current Report Filing (8-k)
October 29 2018 - 05:04PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): October 29,
2018
Commission File Number:
0-24260
AMEDISYS, INC.
(Exact Name of Registrant as specified in its Charter)
|
|
|
Delaware
|
|
11-3131700
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
3854 American Way, Suite A, Baton Rouge, LA 70816
(Address of principal executive offices, including zip code)
(225)
292-2031
or
(800) 467-2662
(Registrants telephone number, including area code)
Check the appropriate box below if
the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
☐ Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
☐ Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
SECTION 2 FINANCIAL INFORMATION
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On October 29, 2018, Amedisys, Inc. (we, us, our or the Company) issued a press release
announcing our financial results for the three and nine-month periods ended September 30, 2018. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
The information presented in Item 2.02 of this Current Report on Form
8-K
and Exhibit 99.1
attached hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, unless we specifically
state that the information is to be considered filed under the Exchange Act or specifically incorporate it by reference in any filing under the Securities Act of 1933, as amended (the Securities Act), or the Exchange Act.
SECTION 7 REGULATION FD
ITEM 7.01. REGULATION FD DISCLOSURE
Item 2.02 of this Current Report on Form
8-K
is incorporated herein by reference.
In addition, a copy of the supplemental slides which will be discussed during the Companys earnings call at 11:00 a.m. ET on Tuesday,
October 30, 2018 is attached to this report as Exhibit 99.2 and incorporated herein by reference.
The information presented in
Item 7.01 of this Current Report on Form
8-K
and Exhibit 99.2 attached hereto shall not be deemed filed for purposes of Section 18 of the Exchange Act, or otherwise subject to the
liabilities of that section, unless we specifically state that the information is to be considered filed under the Exchange Act or specifically incorporate it by reference in any filing under the Securities Act or the Exchange Act.
SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS
(d) Exhibits.
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
AMEDISYS, INC.
(Registrant)
|
|
|
By:
|
|
/s/ Scott G. Ginn
|
|
|
Scott G. Ginn
|
|
|
Chief Financial Officer
|
|
|
(Principal Financial Officer)
|
DATE: October 29, 2018
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Feb 2024 to Mar 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Mar 2023 to Mar 2024